Oncovista Innovative Therapies Stock Price Prediction
| OVIT Stock | USD 0.0001 0.0001 50.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using OncoVista Innovative hype-based prediction, you can estimate the value of OncoVista Innovative Therapies from the perspective of OncoVista Innovative response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in OncoVista Innovative to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying OncoVista because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
OncoVista Innovative after-hype prediction price | USD 1.09E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
OncoVista |
OncoVista Innovative After-Hype Price Prediction Density Analysis
As far as predicting the price of OncoVista Innovative at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in OncoVista Innovative or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of OncoVista Innovative, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
OncoVista Innovative Estimiated After-Hype Price Volatility
In the context of predicting OncoVista Innovative's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on OncoVista Innovative's historical news coverage. OncoVista Innovative's after-hype downside and upside margins for the prediction period are 0.00 and 6.25, respectively. We have considered OncoVista Innovative's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
OncoVista Innovative is out of control at this time. Analysis and calculation of next after-hype price of OncoVista Innovative is based on 3 months time horizon.
OncoVista Innovative Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as OncoVista Innovative is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OncoVista Innovative backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with OncoVista Innovative, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.78 | 6.25 | 0.00 | 2.39 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 8.57 |
|
OncoVista Innovative Hype Timeline
OncoVista Innovative is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -2.39. OncoVista is forecasted to increase in value after the next headline, with the price projected to jump to 1.09E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is estimated to be 8.57%, whereas the daily expected return is now at -0.78%. The volatility of related hype on OncoVista Innovative is about 204.1%, with the expected price after the next announcement by competition of -2.39. The company has return on total asset (ROA) of (23.5768) % which means that it has lost $23.5768 on every $100 spent on assets. This is way below average. OncoVista Innovative's management efficiency ratios could be used to measure how well OncoVista Innovative manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out OncoVista Innovative Basic Forecasting Models to cross-verify your projections.OncoVista Innovative Related Hype Analysis
Having access to credible news sources related to OncoVista Innovative's direct competition is more important than ever and may enhance your ability to predict OncoVista Innovative's future price movements. Getting to know how OncoVista Innovative's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how OncoVista Innovative may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NTII | Neurobiological Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GNCAQ | Genocea Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| POLXF | Polydex Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CYCC | Cyclacel Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.01 | 9.38 | (8.11) | 35.14 | |
| AMLX | Amylyx Pharmaceuticals | (0.04) | 10 per month | 0.00 | (0.07) | 7.20 | (9.09) | 21.45 | |
| AXSM | Axsome Therapeutics | 0.00 | 0 per month | 2.01 | 0.17 | 6.70 | (3.95) | 25.26 | |
| EXEL | Exelixis | (4.92) | 5 per month | 2.56 | 0.07 | 4.41 | (3.83) | 14.29 | |
| VKTX | Viking Therapeutics | 3.04 | 12 per month | 0.00 | (0.10) | 8.39 | (10.98) | 24.65 | |
| MDGL | Madrigal Pharmaceuticals | (25.64) | 8 per month | 3.98 | 0.07 | 7.64 | (5.66) | 23.14 |
OncoVista Innovative Additional Predictive Modules
Most predictive techniques to examine OncoVista price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for OncoVista using various technical indicators. When you analyze OncoVista charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About OncoVista Innovative Predictive Indicators
The successful prediction of OncoVista Innovative stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as OncoVista Innovative Therapies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of OncoVista Innovative based on analysis of OncoVista Innovative hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to OncoVista Innovative's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to OncoVista Innovative's related companies.
Story Coverage note for OncoVista Innovative
The number of cover stories for OncoVista Innovative depends on current market conditions and OncoVista Innovative's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that OncoVista Innovative is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about OncoVista Innovative's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
OncoVista Innovative Short Properties
OncoVista Innovative's future price predictability will typically decrease when OncoVista Innovative's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of OncoVista Innovative Therapies often depends not only on the future outlook of the potential OncoVista Innovative's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OncoVista Innovative's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 208.3 K |
Additional Tools for OncoVista Pink Sheet Analysis
When running OncoVista Innovative's price analysis, check to measure OncoVista Innovative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoVista Innovative is operating at the current time. Most of OncoVista Innovative's value examination focuses on studying past and present price action to predict the probability of OncoVista Innovative's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoVista Innovative's price. Additionally, you may evaluate how the addition of OncoVista Innovative to your portfolios can decrease your overall portfolio volatility.